ArticleCureus2024

Social Interest Data as a Proxy for Off-Label Performance-Enhancing Drug Use: Implications and Clinical Considerations.

Philip A Holubeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.